Detection of P-glycoprotein in Human Cancers
Author Information
Author(s): D. Schlaifer, G. Laurent, S. Chittal, T. Tsuruo, S. Soues, C. Muller, J.Y. Charcosset, C. Alard, P. Brousset, C. Mazerrolles, G. Delsol
Primary Institution: Chu Purpan, Toulouse, France
Hypothesis
The study investigates the expression of P-glycoprotein in various human tumors and its implications for multidrug resistance.
Conclusion
The study found that P-glycoprotein expression is present in some non-lymphoid tumors but not in neoplastic lymphoid cells, suggesting that drug resistance mechanisms may differ.
Supporting Evidence
- P-glycoprotein expression was confirmed in many non-lymphoid tumors.
- Stromal macrophages and endothelial cells frequently stained positive for P-glycoprotein.
- Non-Hodgkin's lymphomas showed no P-glycoprotein expression in neoplastic lymphoid cells.
Takeaway
The researchers looked at cancer samples to see if a protein called P-glycoprotein was present, which can make cancer cells resistant to drugs. They found it in some tumors but not in lymphomas.
Methodology
Immunohistochemical techniques were used to assess P-glycoprotein expression in tumor specimens processed by cryostat and ModAMeX methods.
Limitations
The study did not determine the clinical outcomes related to chemotherapy sensitivity in the tested cases.
Want to read the original?
Access the complete publication on the publisher's website